Targeting KRAS in metastatic colorectal cancer: current strategies and emerging opportunities

Developing drugs that target KRAS, the most frequently mutated oncogene in cancer, has not been successful despite much concerted efforts dedicated towards it in the last thirty years. Considering the key role th...

from Cancer via ola Kala on Inoreader http://ift.tt/2FPqbqf
via IFTTT